HRIA
NVO

Haberer Registered Investment Advisor’s Novo Nordisk NVO Stock Holding History

Haberer Registered Investment Advisor’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-450
Closed -$11K – 356
2014
Q3 		$11K Hold
450
– – 0.01% 265
2014
Q2 		$10K Hold
450
– – ﹤0.01% 276
2014
Q1 		$10K Hold
450
– – ﹤0.01% 269
2013
Q4 		$8K Hold
450
– – ﹤0.01% 283
2013
Q3 		$8K Buy
+450
New +$7.57K ﹤0.01% 308

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Haberer Registered Investment Advisor's NVO Position: Q4 2014 in Review

Haberer Registered Investment Advisor sold out of Novo Nordisk (NVO) in Q4 2014, closing a stake of 450 shares — an estimated $11K sold.

Haberer Registered Investment Advisor first reported a position in NVO in Q3 2013 and held it in 5 quarters. The position peaked at $11K in Q3 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

  • Haberer Registered Investment Advisor reported no remaining Novo Nordisk position as of Q4 2014 after selling out during the quarter.
  • Haberer Registered Investment Advisor sold 450 Novo Nordisk shares in Q4 2014, an estimated $11K.
  • Haberer Registered Investment Advisor first reported a position in Novo Nordisk in Q3 2013 and held it in 5 quarters.
  • Haberer Registered Investment Advisor's Novo Nordisk position peaked at $11K in Q3 2014.
  • 500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Haberer Registered Investment Advisor's 13F filing for Q4 2014, filed 13 Jan 2015.